Medicare Enrolled

Dr. John Zeroogian, M.D.

Gastroenterology · Pasadena, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
630 S RAYMOND AVE UNIT 240, Pasadena, CA 91105
6264499920
In practice since 2005 (20 years)
NPI: 1437149226 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Zeroogian from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Zeroogian? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Zeroogian

Dr. John Zeroogian is a gastroenterology specialist in Pasadena, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Zeroogian performed 740 Medicare services across 408 unique beneficiaries.

Between the years covered by Open Payments, Dr. Zeroogian received a total of $15,480 from 45 pharmaceutical and/or device companies across 638 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Zeroogian is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 48% volume in CA $15,480 industry payments

Medicare Practice Summary

Medicare Utilization ↗
740
Medicare services
Top 48% in CA for gastroenterology
408
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~37 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
227 $41 $240
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
134 $53 $300
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
93 $217 $1,081
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
72 $100 $600
Moderate sedation during GI endoscopy
Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient.
45 $3 $38
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
37 $72 $620
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
37 $106 $780
External hemorrhoid removal by rubber banding
A procedure to remove external hemorrhoids using rubber bands to cut off blood supply. The affected tissue is tied off and eventually falls off.
29 $234 $1,420
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
17 $181 $820
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
15 $185 $820
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
12 $101 $863
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
11 $128 $820
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
11 $58 $540
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,480
Total received (2018-2024)
Avg $2,211/year across 7 years
Top 13% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
638
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,480 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,642
2023
$2,345
2022
$3,771
2021
$3,385
2020
$1,575
2019
$933
2018
$830

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$976
Phathom Pharmaceuticals, Inc.
$434
Janssen Biotech, Inc.
$352
Celltrion USA Inc.
$175
Takeda Pharmaceuticals U.S.A., Inc.
$117
QOL Medical, LLC
$99
Celgene Corporation
$88
PFIZER INC.
$63
AIMMUNE THERAPEUTICS, INC.
$61
Gilead Sciences, Inc.
$57
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56
Merck Sharp & Dohme LLC
$52
Lilly USA, LLC
$44
GENZYME CORPORATION
$36
Organon Llc
$32
Top 3 companies account for 66.7% of 2024 payments
All-time payments by company (2018-2024) ›
AbbVie Inc.
$2,578
ABBVIE INC.
$2,417
Janssen Biotech, Inc.
$1,765
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,288
Takeda Pharmaceuticals U.S.A., Inc.
$1,057
AbbVie, Inc.
$726
PFIZER INC.
$529
RedHill Biopharma Inc.
$510
E.R. Squibb & Sons, L.L.C.
$472
Phathom Pharmaceuticals, Inc.
$455
QOL Medical, LLC
$399
Merck Sharp & Dohme LLC
$345
Intercept Pharmaceuticals, Inc.
$309
Gilead Sciences, Inc.
$266
Celgene Corporation
$248
Ardelyx, Inc.
$196
Celltrion USA Inc.
$175
GENZYME CORPORATION
$169
Apollo Endosurgery US Inc
$139
Merck Sharp & Dohme Corporation
$129
Janssen Scientific Affairs, LLC
$125
Boston Scientific Corporation
$120
Ironwood Pharmaceuticals, Inc
$95
Fresenius Kabi USA, LLC
$90
IRONWOOD PHARMACEUTICALS, INC
$84
Amgen Inc.
$72
Nestle HealthCare Nutrition Inc.
$70
Lucid Diagnostics Inc.
$70
Regeneron Healthcare Solutions, Inc.
$67
AIMMUNE THERAPEUTICS, INC.
$61
Alfasigma USA, Inc.
$48
Braintree Laboratories, Inc.
$46
Lilly USA, LLC
$44
AstraZeneca Pharmaceuticals LP
$38
UCB, Inc.
$34
Ferring Pharmaceuticals Inc.
$32
Organon Llc
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
SANOFI-AVENTIS U.S. LLC
$28
Medtronic, Inc.
$25
INTERCEPT PHARMACEUTICALS, INC.
$24
Evoke Pharma, Inc.
$21
Allergan Inc.
$20
GlaxoSmithKline, LLC.
$16
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 43.7% of all-time payments
Associated products mentioned in payments ›
Amitiza · BENLYSTA · CLENPIQ · CREON · CYLTEZO · Cimzia · DIFICID · DUPIXENT · ENTYVIO · Enbrel · Entyvio · FARXIGA · GATTEX · GENERAL ENDOCHOICE · GI Genius · GIMOTI · HADLIMA · HUMIRA · Humira · IBSRELA · IDACIO · INFLECTRA · JANUVIA · LINZESS · Linzess · MAVYRET · MOTEGRITY · Mavyret · Movantik · OCALIVA · OMVOH · OverStitch Endoscopic Suturing System · PLENVU · REBYOTA · REMICADE · RINVOQ · SIMPONI · SIMPONI ARIA · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUPREP BOWEL PREP · SUTAB · Spotlight · Sucraid · TOUJEO · TREMFYA · TRULANCE · Talicia · UCERIS · Uloric · VEGZELMA · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · VRAYLAR · XARELTO · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · ZYMFENTRA · Zelnorm
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a gastroenterology specialist in Pasadena?
Compare gastroenterologists in the Pasadena area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
464
Per 100K population
4.7
County median income
$87,760
Nearest hospital
GLENDALE ADVENTIST MEDICAL CENTER
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Zeroogian is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 13% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Zeroogian experienced with chronic care management, additional 20 min/month?
Based on Medicare claims data, Dr. Zeroogian performed 227 chronic care management, additional 20 min/month services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Zeroogian receive payments from pharmaceutical companies?
Yes. Dr. Zeroogian received a total of $15,480 from 45 companies across 638 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Zeroogian's costs compare to other gastroenterologists in Pasadena?
Dr. Zeroogian's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Zeroogian) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →